EBS vs WRK
Emergent Biosolutions Inc (EBS) versus WRK (WRK) — a side-by-side from cached financials, not a winner call.
Emergent Biosolutions Inc (EBS) is a drug manufacturers - specialty & generic company listed on US.
WRK (WRK) common stock.
Latest reported EBS revenue for 2026-06-30 was $390.4M. Net income was -$173.4M. EBS currently screens at market cap $416.4M.
WRK does not have a complete income-statement cache yet.
EBS currently screens at market cap $416.4M.
Not investment advice. Open the EBS and WRK stock pages for the full models.
Not investment advice.